 <h1>Betaxolol Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of betaxolol include:</b> headache. <b>Other side effects include:</b> bradycardia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to betaxolol: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, betaxolol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking betaxolol:</p><p>
<i>More common</i>
</p><ul>
<li>Chest pain or discomfort</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>shortness of breath</li>
<li>slow or irregular heartbeat</li>
<li>unusual tiredness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Cold arms, legs, hands, or feet</li>
<li>difficult or labored breathing</li>
<li>fast, pounding, or racing heartbeat or pulse</li>
<li>swelling of face, fingers, feet, or lower legs</li>
<li>tightness in the chest</li>
<li>wheezing</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking betaxolol:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Anxiety</li>
<li>blurred vision</li>
<li>chills</li>
<li>cold sweats</li>
<li>coma</li>
<li>confusion</li>
<li>convulsions (seizures)</li>
<li>cool, pale skin</li>
<li>decreased urine output</li>
<li>depression</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly</li>
<li>extreme fatigue</li>
<li>headache</li>
<li>increased hunger</li>
<li>irregular breathing</li>
<li>loss of consciousness</li>
<li>nervousness</li>
<li>nightmares</li>
<li>noisy breathing</li>
<li>shakiness</li>
<li>slurred speech</li>
<li>sweating</li>
<li>troubled breathing</li>
<li>weight gain</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of betaxolol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Joint pain</li>
<li>nausea</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>body aches or pain</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>congestion</li>
<li>decreased interest in sexual intercourse</li>
<li>diarrhea</li>
<li>difficulty in moving</li>
<li>dryness or soreness of throat</li>
<li>fever</li>
<li>heartburn</li>
<li>hoarseness</li>
<li>inability to have or keep an erection</li>
<li>indigestion</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>muscle pain or stiffness</li>
<li>rash</li>
<li>runny nose</li>
<li>sleeplessness</li>
<li>sneezing</li>
<li>stomach discomfort, upset, or pain</li>
<li>stuffy nose</li>
<li>tender, swollen glands in neck</li>
<li>trouble in swallowing</li>
<li>trouble sleeping</li>
<li>unable to sleep</li>
<li>unusual drowsiness, dullness, or feeling of sluggishness</li>
<li>unusual or strange dreams</li>
<li>voice changes</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Discouragement</li>
<li>feeling sad or empty</li>
<li>irritability</li>
<li>lack of appetite</li>
<li>loss of interest or pleasure</li>
<li>tiredness</li>
<li>trouble concentrating</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to betaxolol: oral tablet</i></p><h3>General</h3><p>The more commonly reported side effects include bradycardia, fatigue, lethargy, and headache.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Chest pain, bradycardia, edema, palpitations, cold extremities</p>
<p><b>Frequency not reported</b>: Angina pectoris, arrhythmia, atrioventricular (AV) block, heart failure, hypertension, hypotension, myocardial infarction, thrombosis, thrombophlebitis, peripheral ischemia, intermittent claudication<sup>[Ref]</sup></p><p>Bradycardia occurred as a dose-related effect in clinical trials.  In clinical trials, bradycardia occurred in 8.1% of patients given this drug compared to 12% of patients given equivalent doses of atenolol.  Symptomatic bradycardia occurred in 0.8% of patients taking this drug versus 1.4% of patients treated with equivalent doses of propranolol.  </p>
<p></p>
<p>Angina pectoris, arrhythmia, AV block, heart failure, hypertension, hypotension, myocardial infarction, thrombosis, syncope, cerebrovascular disorder, intermittent claudication, peripheral ischemia, and thrombophlebitis occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Bronchitis, bronchospasm, cough, epistaxis, pneumonia, and sinusitis occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Dyspnea, pharyngitis, rhinitis, upper respiratory infection</p>
<p><b>Frequency not reported</b>: Bronchitis, bronchospasm, cough, epistaxis, pneumonia, sinusitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Twitching, arthropathy, neck pain, muscle cramps, tendonitis, and leg cramps occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Joint pain, myalgia, arthralgia</p>
<p><b>Frequency not reported</b>: Twitching, arthropathy, neck pain, muscle cramps, tendonitis, leg cramps<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Ataxia, neuralgia, neuropathy, numbness, speech disorder, stupor, tremor, syncope, amnesia, impaired concentration, taste loss, cerebrovascular disorder, and abnormal taste occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Headache, dizziness, paresthesia, lethargy</p>
<p><b>Frequency not reported</b>: Ataxia, neuralgia, neuropathy, numbness, speech disorder, stupor, tremor, syncope, amnesia, impaired concentration, taste loss, cerebrovascular disorder, abnormal taste<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, dyspepsia, diarrhea</p>
<p><b>Frequency not reported</b>: Salivation, mouth ulceration, rectal disorders, vomiting, dysphagia, constipation, dry mouth<sup>[Ref]</sup></p><p>Salivation, mouth ulceration, dry mouth, rectal disorders, vomiting, dysphagia, and constipation occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Anemia, leukocytosis, lymphadenopathy, and thrombocytopenia occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Anemia, leukocytosis, lymphadenopathy, thrombocytopenia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Impotence</p>
<p><b>Frequency not reported</b>: Menstrual disorder, Peyronie's disease, prostatitis, proteinuria, micturition disorder, dysuria<sup>[Ref]</sup></p><p>Menstrual disorder, Peyronie's disease, prostatitis, proteinuria, dysuria, and micturition disorder occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Flushing, sweating, purpura, pruritus, skin disorders, hypertrichosis, erythematous rash, eczema, and alopecia occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Frequency not reported</b>: Flushing, sweating, purpura, skin disorders, hypertrichosis, erythematous rash, eczema, alopecia, pruritus<sup>[Ref]</sup></p><h3>Immunologic</h3><p>In clinical trials, ANA conversion occurred in 5.3%, 6.3%, 4.9%, and 3.2% of patients taking this drug, atenolol, propranolol, and placebo, respectively.  </p>
<p></p>
<p>Flu occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Antinuclear antibody (ANA) development</p>
<p><b>Frequency not reported</b>: Flu<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Nervousness, bizarre dreams, depression, insomnia</p>
<p><b>Frequency not reported</b>: Abnormal thinking, confusion, emotional lability, hallucinations, decreased libido<sup>[Ref]</sup></p><p>Abnormal thinking, confusion, emotional lability, hallucinations, and decreased libido occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Anorexia, increased appetite, acidosis, hypercholesterolemia, hyperglycemia, hyperkalemia, hyperlipidemia, hyperuricemia, hypokalemia, weight gain, weight loss, increased LDH, diabetes occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Anorexia, increased appetite, hypercholesterolemia, hyperglycemia, hyperkalemia, hyperlipidemia, hyperuricemia, hypokalemia, weight gain, weight loss, increased LDH, acidosis, diabetes<sup>[Ref]</sup></p><h3>Ocular</h3><p>Scotoma, ocular hemorrhage, iritis, dry eyes, conjunctivitis, cataract, blepharitis, abnormal lacrimation, and abnormal vision occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Scotoma, ocular hemorrhage, iritis, dry eyes, conjunctivitis, cataract, blepharitis, abnormal lacrimation, abnormal vision<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Fever, malaise, pain, rigors, asthenia, fatigue, earache, labyrinth disorders, deafness, thirst, breast pain, tinnitus<sup>[Ref]</sup></p><p>Fever, malaise, pain, rigors, earache, labyrinth disorders, deafness, thirst, breast pain, and tinnitus occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Renal pain, oliguria, cystitis, abnormal renal function<sup>[Ref]</sup></p><p>Renal pain, oliguria, cystitis, and abnormal renal function occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Increased liver transaminases<sup>[Ref]</sup></p><p>Increased liver transaminases occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Breast fibroadenosis<sup>[Ref]</sup></p><p>Breast fibroadenosis occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Allergy occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Allergy<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Kerlone (betaxolol)." Searle, Skokie, IL. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about betaxolol</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: cardioselective beta blockers</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Betaxolol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Kerlone</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Angina Pectoris Prophylaxis</li>
<li>High Blood Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to betaxolol: oral tablet</i></p><h3>General</h3><p>The more commonly reported side effects include bradycardia, fatigue, lethargy, and headache.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Chest pain, bradycardia, edema, palpitations, cold extremities</p><p><b>Frequency not reported</b>: Angina pectoris, arrhythmia, atrioventricular (AV) block, heart failure, hypertension, hypotension, myocardial infarction, thrombosis, thrombophlebitis, peripheral ischemia, intermittent claudication<sup>[Ref]</sup></p><p>Bradycardia occurred as a dose-related effect in clinical trials.  In clinical trials, bradycardia occurred in 8.1% of patients given this drug compared to 12% of patients given equivalent doses of atenolol.  Symptomatic bradycardia occurred in 0.8% of patients taking this drug versus 1.4% of patients treated with equivalent doses of propranolol.  </p><p></p><p>Angina pectoris, arrhythmia, AV block, heart failure, hypertension, hypotension, myocardial infarction, thrombosis, syncope, cerebrovascular disorder, intermittent claudication, peripheral ischemia, and thrombophlebitis occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Bronchitis, bronchospasm, cough, epistaxis, pneumonia, and sinusitis occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Dyspnea, pharyngitis, rhinitis, upper respiratory infection</p><p><b>Frequency not reported</b>: Bronchitis, bronchospasm, cough, epistaxis, pneumonia, sinusitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Twitching, arthropathy, neck pain, muscle cramps, tendonitis, and leg cramps occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Joint pain, myalgia, arthralgia</p><p><b>Frequency not reported</b>: Twitching, arthropathy, neck pain, muscle cramps, tendonitis, leg cramps<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Ataxia, neuralgia, neuropathy, numbness, speech disorder, stupor, tremor, syncope, amnesia, impaired concentration, taste loss, cerebrovascular disorder, and abnormal taste occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Headache, dizziness, paresthesia, lethargy</p><p><b>Frequency not reported</b>: Ataxia, neuralgia, neuropathy, numbness, speech disorder, stupor, tremor, syncope, amnesia, impaired concentration, taste loss, cerebrovascular disorder, abnormal taste<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, dyspepsia, diarrhea</p><p><b>Frequency not reported</b>: Salivation, mouth ulceration, rectal disorders, vomiting, dysphagia, constipation, dry mouth<sup>[Ref]</sup></p><p>Salivation, mouth ulceration, dry mouth, rectal disorders, vomiting, dysphagia, and constipation occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Anemia, leukocytosis, lymphadenopathy, and thrombocytopenia occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Anemia, leukocytosis, lymphadenopathy, thrombocytopenia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Impotence</p><p><b>Frequency not reported</b>: Menstrual disorder, Peyronie's disease, prostatitis, proteinuria, micturition disorder, dysuria<sup>[Ref]</sup></p><p>Menstrual disorder, Peyronie's disease, prostatitis, proteinuria, dysuria, and micturition disorder occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Flushing, sweating, purpura, pruritus, skin disorders, hypertrichosis, erythematous rash, eczema, and alopecia occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Rash</p><p><b>Frequency not reported</b>: Flushing, sweating, purpura, skin disorders, hypertrichosis, erythematous rash, eczema, alopecia, pruritus<sup>[Ref]</sup></p><h3>Immunologic</h3><p>In clinical trials, ANA conversion occurred in 5.3%, 6.3%, 4.9%, and 3.2% of patients taking this drug, atenolol, propranolol, and placebo, respectively.  </p><p></p><p>Flu occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Antinuclear antibody (ANA) development</p><p><b>Frequency not reported</b>: Flu<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Nervousness, bizarre dreams, depression, insomnia</p><p><b>Frequency not reported</b>: Abnormal thinking, confusion, emotional lability, hallucinations, decreased libido<sup>[Ref]</sup></p><p>Abnormal thinking, confusion, emotional lability, hallucinations, and decreased libido occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Anorexia, increased appetite, acidosis, hypercholesterolemia, hyperglycemia, hyperkalemia, hyperlipidemia, hyperuricemia, hypokalemia, weight gain, weight loss, increased LDH, diabetes occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Anorexia, increased appetite, hypercholesterolemia, hyperglycemia, hyperkalemia, hyperlipidemia, hyperuricemia, hypokalemia, weight gain, weight loss, increased LDH, acidosis, diabetes<sup>[Ref]</sup></p><h3>Ocular</h3><p>Scotoma, ocular hemorrhage, iritis, dry eyes, conjunctivitis, cataract, blepharitis, abnormal lacrimation, and abnormal vision occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Scotoma, ocular hemorrhage, iritis, dry eyes, conjunctivitis, cataract, blepharitis, abnormal lacrimation, abnormal vision<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Fever, malaise, pain, rigors, asthenia, fatigue, earache, labyrinth disorders, deafness, thirst, breast pain, tinnitus<sup>[Ref]</sup></p><p>Fever, malaise, pain, rigors, earache, labyrinth disorders, deafness, thirst, breast pain, and tinnitus occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Renal pain, oliguria, cystitis, abnormal renal function<sup>[Ref]</sup></p><p>Renal pain, oliguria, cystitis, and abnormal renal function occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Increased liver transaminases<sup>[Ref]</sup></p><p>Increased liver transaminases occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Breast fibroadenosis<sup>[Ref]</sup></p><p>Breast fibroadenosis occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Allergy occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Allergy<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Kerlone (betaxolol)." Searle, Skokie, IL. </p><h2>More about betaxolol</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: cardioselective beta blockers</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Betaxolol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Angina Pectoris Prophylaxis</li>
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>